STAT3 is constitutively activated and/or overexpressed in many tumor cells including non-small cell carcinoma, breast carcinoma, melanoma, and leukemia cells [36–39], and the inhibition of STAT3 in these cells affects their survival and growth. This evidence concerns the gene STAT3 and breast carcinoma.